A
2.65
0.08 (3.11%)
市场趋势
| 短期 | 中期 | ||
| 行业 | Biotechnology (US) | 混合的 | 看跌 |
| Biotechnology (全球的) | 混合的 | 看跌 | |
| 股票 | Alto Neuroscience, Inc. | 看涨 | 看跌 |
AIStockmoo 评分
0.4
| 分析师共识 | 1.5 |
| 内部交易活动 | NA |
| 价格波动 | -2.0 |
| 技术平均移动指标 | 0.0 |
| 技术振荡指标 | 2.0 |
| 平均 | 0.38 |
|
Alto Neuroscience Inc is a clinical-stage biopharmaceutical company with a mission to redefine psychiatry by leveraging individuals’ neurobiology to develop personalized and effective treatment options. The company currently consists of different clinical-stage assets such as ALTO-100, ALTO-202, ALTO-101, and ALTO-300 among others initially targeting depressive disorders and schizophrenia populations as identified by independent brain-based biomarkers. |
|
| 部门 | Healthcare |
| 行业 | Biotechnology |
| 内部持股比例 | 7.48% |
| 机构持股比例 | 77.52% |
所有权
| 姓名 | 日期 | 持有股份 |
|---|---|---|
| Alpha Wave Global, Lp | 31 Mar 2025 | 3,707,757 |
| Vestal Point Capital, Lp | 31 Mar 2025 | 915,000 |
| 72 Investment Holdings, Llc | 31 Mar 2025 | 667,778 |
| 52周波幅 | ||
| 中 | 10.00 (277.36%) | |
| 总计 | 1 购买 | |
| 公司 | 日期 | 目标价格 | 调整类型 | 价格@调整类型 |
|---|---|---|---|---|
| HC Wainwright & Co. | 18 Aug 2025 | 10.00 (277.36%) | 购买 | 3.41 |
| 26 Jun 2025 | 10.00 (277.36%) | 购买 | 2.30 |
该时间范围内无数据。
支撑、阻力和趋势线水平是由人工智能（AI）模型生成的，请谨慎解读。
投资组合